Trade Mark Journal No.2026/045 6 November 2026

UK00004466239 27 October 2026 (5)

BRISDELLE

Class 5: Pharmaceutical preparations and substances for use in the treatment, alleviation and prevention of thermoregulatory dysfunctions and vasomotor symptoms including hot flashes, hot flushes, night awakenings, night sweats, and such disorders and conditions associated with perimenopause, menopause and hormonal deficiencies.

Legacy Pharma Inc. SEZC

Representative: Gill Jennings & Every LLP